Gh Research Plc
Officers & Directors
The company's executive officers include Velichka Valcheva, Chief Executive Officer since September 2024, who has over 20 years of experience in pharmaceutical and biotech leadership and previously served as Chief Medical Officer and Vice President of Clinical Research and Medical Affairs at the company. Magnus Halle has been Managing Director, Ireland since November 2020; he is a co-founder and former consultant, analyst, and Money Laundering Reporting Officer at NB Capital ApS. Julie Ryan has served as Vice President, Finance since January 2021 and holds qualifications as a chartered accountant, with prior senior finance roles at Ardagh Group plc, Sherry FitzGerald, ICON plc, and Brambles Ltd. Aaron Cameron has been Chief Operating Officer since January 2024, having previously held the position of Vice President Technical Development and Operational Planning, and senior roles at Viatris, Iterum Therapeutics, Mylan, and MSD. The non-executive directors include Florian Schönharting, Chairman of the Board since 2018, who is a co-founder of the company and several biopharmaceutical firms such as Forward Pharma A/S, Genmab A/S, Veloxis A/S, Zealand Pharma A/S, and Acadia Pharmaceuticals Inc., with over 25 years of experience as an investment executive in biopharma funds.
Gh Research Plc currently has 73 employees.
|
